Synergistic Effect of Combined Growth Factors in Porcine Intervertebral Disc Degeneration

References

• Luoma, K., Riihimaki, H., Luukkonen, R., Raininko, R., Viikari-Juntura, E., and Lamminen, A. (2000). Low back pain in relation to lumbar disc degeneration. Spine (Phila Pa 1976). 25:487–492.
   Google Scholar
• Hoy, D.G., Protani, M., De, R., and Buchbinder, R. (2010). The epidemiology of neck pain. Best Pract. Res. Clin. Rheumatol. 24:783–792.
   PubMed Web of Science ®Google Scholar
• Banes, A.J., Link, G.W., Gilbert, J.W., Tran Son Tay, R., and Monbureau, O. (1990). Culturing cells in a mechanically active environment. Am. Biotechnol. Lab. 8:12–22.
   PubMed Web of Science ®Google Scholar
• Cs-Szabo, G., Ragasa-San Juan, D., Turumella, V., Masuda, K., Thonar, E., and An, H.S. (2002). Changes in mRNA and protein levels of proteoglycans of the anulus fibrosus and nucleus pulposus during intervertebral disc degeneration. Spine (Phila Pa 1976). 27:2212–2219.
   PubMed Web of Science ®Google Scholar
• Ganey, T., Libera, J., Moos, V., Alasevic, O., Fritsch, K.G., Meisel, H.J., and Hutton, W.C. (2003). Disc chondrocyte transplantation in a canine model: A treatment for degenerated or damaged intervertebral disc. Spine (Phila Pa 1976). 28:2609–2620.
   PubMed Web of Science ®Google Scholar
• Kang, J.D., Georgescu, H.I., McIntyre-Larkin, L., Stefanovic-Racic, M., Donaldson, W.F. 3rd, and Evans, C.H. (1996). Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine (Phila Pa 1976). 21:271–277.
   PubMed Web of Science ®Google Scholar
• Le Maitre, C.L., Freemont, A.J., and Hoyland, J.A. (2004). Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J. Pathol. 204:47–54.
   PubMed Web of Science ®Google Scholar
• Boos, N., Nerlich, A.G., Wiest, I., von der Mark, K., and Aebi, M. (1997). Immunolocalization of type X collagen in human lumbar intervertebral discs during ageing and degeneration. Histochem. Cell Biol. 108:471–480.
   PubMed Web of Science ®Google Scholar
• Sive, J.I., Baird, P., Jeziorsk, M., Watkins, A., Hoyland, J.A., and Freemont, A.J. (2002). Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol. Pathol. 55:91–97.
   PubMedGoogle Scholar
• Fujisawa, T., Hattori, T., Takahashi, K., Kuboki, T., Yamashita, A., and Takigawa, M. (1999). Cyclic mechanical stress induces extracellular matrix degradation in cultured chondrocytes via gene expression of matrix metalloproteinases and interleukin-1. J. Biochem. 125:966–975.
   PubMed Web of Science ®Google Scholar
• Sandy, J.D., Thompson, V., Doege, K., and Verscharen, C. (2000). The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1. Biochem. J. 351:161–166.
   PubMed Web of Science ®Google Scholar
• Le Maitre, C.L., Freemont, A.J., and Hoyland, J.A. (2005). The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res. Ther. 7:732–745.
   PubMed Web of Science ®Google Scholar
• Igarashi, T., Kikuchi, S., Shubayev, V., and Myers, R. (2000). 2000 Volvo Award winner in basic science studies: Exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine (Phila Pa 1976). 25:2975–2980.
   PubMed Web of Science ®Google Scholar
• Taylor, T.K., Melrose, J., Burkhardt, D., Ghosh, P., Claes, L.E., Kettler, A., and Wilke, H.J. (2000). Spinal biomechanics and aging are major determinants of the proteoglycan metabolism of intervertebral disc cells. Spine (Phila Pa 1976). 25:3014–3020.
   PubMed Web of Science ®Google Scholar
• Fukui, N., Zhu, Y., Maloney, W.J., Clohisy, J., and Sandell, L.J. (2003). Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J. Bone Joint Surg. Am. 85-A(Suppl. 3):59–66.
   PubMed Web of Science ®Google Scholar
• Walsh, A.J., Bradford, D.S., and Lotz, J.C. (2004). In vivo growth factor treatment of degenerated intervertebral discs. Spine (Phila Pa 1976). 29:156–163.
   PubMed Web of Science ®Google Scholar
• Le Maitre, L., Hoyland, J.A., and Freemont, A.J. (2007). Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile. Arthritis Res. Ther. 9:R77.
   PubMed Web of Science ®Google Scholar
• Shamji, M.F., Setton, L.A., Jarvis, W., So, S., Chen, J., Jing, L., Bullock, R., Isaacs, R.E., Brown, C., and Richardson, W.J. (2010). Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis Rheum. 62:1974–1982.
   PubMed Web of Science ®Google Scholar
• Lee, J.Y., Hall, R., Pelinkovic, D., Cassinelli, E., Usas, A., Gilbertson, L., Huard, J., and Kang, J. (2001). New use of a three-dimensional pellet culture system for human intervertebral disc cells: Initial characterization and potential use for tissue engineering. Spine (Phila Pa 1976). 26:2316–2322.
   PubMed Web of Science ®Google Scholar
• Moon, S.H., Nishida, K., Gilbertson, L.G., Lee, H.M., Kim, H., Hall, R.A., Robbins, P.D., and Kang, J.D. (2008). Biologic response of human intervertebral disc cells to gene therapy cocktail. Spine (Phila Pa 1976). 33:1850–1855.
   PubMed Web of Science ®Google Scholar
• Kim, D.J., Moon, S.H., Kim, H., Kwon, U.H., Park, M.S., Han, K.J., Hahn, S.B., and Lee, H.M. (2003). Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells. Spine (Phila Pa 1976). 28:2679–2684.
   PubMed Web of Science ®Google Scholar
• Li, J., Yoon, S.T., and Hutton, W.C. (2004). Effect of bone morphogenetic protein-2 (BMP-2) on matrix production, other BMPs, and BMP receptors in rat intervertebral disc cells. J. Spinal Disord. Tech. 17:423–428.
   PubMed Web of Science ®Google Scholar
• Kim, H., Lee, J.U., Moon, S.H., Kim, H.C., Kwon, U.H., Seol, N.H., Kim, H.J., Park, J.O., Chun, H.J., Kwon, I.K., and Lee, H.M. (2009). Zonal responsiveness of the human intervertebral disc to bone morphogenetic protein-2. Spine (Phila Pa 1976). 34:1834–1838.
   PubMed Web of Science ®Google Scholar
• Huang, J., Ballou, L.R., and Hasty, K.A. (2007). Cyclic equibiaxial tensile strain induces both anabolic and catabolic responses in articular chondrocytes. Gene. 404:101–109.
   PubMed Web of Science ®Google Scholar
• Overbergh, L., Valckx, D., Waer, M., and Mathieu, C. (1999). Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine. 11:305–312.
   PubMed Web of Science ®Google Scholar
• Giulietti, A., Overbergh, L., Valckx, D., Decallonne, B., Bouillon, R., and Mathieu, C. (2001). An overview of real-time quantitative PCR: Applications to quantify cytokine gene expression. Methods. 25:386–401.
   PubMed Web of Science ®Google Scholar
• Masuda, K., and An, H.S. (2004). Growth factors and the intervertebral disc. Spine J. 4:330S–340S.
   PubMedGoogle Scholar
• Antoniou, J., Steffen, T., Nelson, F., Winterbottom, N., Hollander, A.P., Poole, R.A., Aebi, M., and Alini, M. (1996). The human lumbar intervertebral disc: Evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J. Clin. Invest. 98:996–1003.
   PubMed Web of Science ®Google Scholar
• Cho, H., Park, S.H., Lee, S., Kang, M., Hasty, K.A., and Kim, S.J. (2011). Snapshot of degenerative aging of porcine intervertebral disc: A model to unravel the molecular mechanisms. Exp. Mol. Med. 43:334–340.
   PubMed Web of Science ®Google Scholar
• Tow, B.P., Hsu, W.K., and Wang, J.C. (2007). Disc regeneration: A glimpse of the future. Clin. Neurosurg. 54:122–128.
   PubMedGoogle Scholar
• Murakami, H., Yoon, S.T., Attallah-Wasif, E.S., Tsai, K.J., Fei, Q., and Hutton, W.C. (2006). The expression of anabolic cytokines in intervertebral discs in age-related degeneration. Spine (Phila Pa 1976). 31:1770–1774.
   PubMed Web of Science ®Google Scholar
• Sobajima, S., Kim, J.S., Gilbertson, L.G., and Kang, J.D. (2004). Gene therapy for degenerative disc disease. Gene. Ther. 11:390–401.
   PubMed Web of Science ®Google Scholar
• Evans, C. (2006). Potential biologic therapies for the intervertebral disc. J. Bone Joint Surg. Am. 88(Suppl 2):95–98.
   PubMedGoogle Scholar
• Thompson, J.P., Oegema, T.R., and Bradford, D.S. (1991). Stimulation of mature canine intervertebral disc by growth factors. Spine (Phila Pa 1976). 16:253–260.
   PubMed Web of Science ®Google Scholar
• Longo, U.G., Petrillo, S., Franceschetti, E., Maffulli, N., and Denaro, V. (2012). Growth factors and anticatabolic substances for prevention and management of intervertebral disc degeneration. Stem Cells Int. 2012:1–12.
   Google Scholar
• Matsunaga, S., Nagano, S., Onishi, T., Morimoto, N., Suzuki, S., and Komiya, S. (2003). Age-related changes in expression of transforming growth factor-β and receptors in cells of intervertebral discs. J. Neurosurg. 98(1):63–67.
   PubMed Web of Science ®Google Scholar
• Specchia, N., Pagnotta, A., Toesca, A., and Greco, F. (2002). Cytokines and growth factors in the protruded intervertebral disc of the lumbar spine. Eur. Spine J. 11(2):145–151.
   PubMed Web of Science ®Google Scholar